The Association Between Blood Pressure and Incident Alzheimer Disease: A Systematic Review and Meta-analysis

Background: Many epidemiologic studies have considered the association between blood pressure (BP) and Alzheimer disease, yet the relationship remains poorly understood. Methods: In parallel with work on the AlzRisk online database (www.alzrisk.org), we conducted a systematic review to identify all epidemiologic studies meeting prespecified criteria reporting on the association between hypertension, systolic BP, or diastolic BP and incident Alzheimer disease. When possible, we computed summary measures using random-effects models and explored potential heterogeneity related to age at BP assessment. Results: Eighteen studies reporting on 19 populations met the eligibility criteria. We computed summary relative risks (RR&Sgr;) for 3 measures of BP: hypertension (RR&Sgr; = 0.97 [95% confidence interval = 0.80–1.16]); a 10-mm Hg increase in systolic BP (RR&Sgr; = 0.95 [0.91–1.00]); and a 10-mm Hg increase in diastolic BP (RR&Sgr; = 0.94 [0.85–1.04]). We were unable to compute summary estimates for the association between categories of systolic or diastolic BP and Alzheimer disease; however, there did not appear to be a consistent pattern across studies. After stratifying on age at BP assessment, we found a suggestion of an inverse association between late-life hypertension and Alzheimer disease and a suggestion of an adverse association between midlife diastolic hypertension and Alzheimer disease. Conclusions: Based on existing epidemiologic research, we cannot determine whether there is a causal association between BP and Alzheimer disease. Selection bias and reverse causation may account for the suggested inverse association between late-life hypertension on Alzheimer disease, but, given the expected direction of these biases, they are less likely to account for the suggestion that midlife hypertension increases risk. We advocate continuing systematic review; the AlzRisk database entry on this topic (www.alzrisk.org), which was completed in parallel with this work, will be updated as new studies are published.

[1]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[2]  Norbert Schuff,et al.  ASL Perfusion MRI Predicts Cognitive Decline and Conversion From MCI to Dementia , 2010, Alzheimer disease and associated disorders.

[3]  G. Donnan,et al.  Risk factors for lacunar stroke: A case-control transesophageal echocardiographic study , 2000, Neurology.

[4]  M. D. O'Brien,et al.  Cerebral blood flow in dementia , 1986, Neurology.

[5]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[6]  C. Brayne,et al.  A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. , 2005, Journal of clinical epidemiology.

[7]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[8]  Eduardo Fasce,et al.  Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile , 2007, Journal of hypertension.

[9]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[10]  Warren J Manning,et al.  Cardiac Index Is Associated With Brain Aging: The Framingham Heart Study , 2010, Circulation.

[11]  J. Dickens,et al.  Risk factors for incident Alzheimer's disease in African Americans and Yoruba , 2006, Metabolic Brain Disease.

[12]  H. Chabriat,et al.  Cortical Neuronal Apoptosis in CADASIL , 2006, Stroke.

[13]  S. Greenland.  Quantifying Biases in Causal Models: Classical Confounding vs Collider-Stratification Bias , 2003, Epidemiology.

[14]  A. Hofman,et al.  Blood Pressure and Risk of Dementia: Results from the Rotterdam Study and the Gothenburg H-70 Study , 2000, Dementia and Geriatric Cognitive Disorders.

[15]  V. Haroutunian,et al.  Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons , 2009, Neurology.

[16]  D. Bennett,et al.  Relation of Blood Pressure to Risk of Incident Alzheimer’s Disease and Change in Global Cognitive Function in Older Persons , 2005, Neuroepidemiology.

[17]  B. Winblad,et al.  The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.

[18]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[19]  C. Iadecola,et al.  Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia , 2003, Stroke.

[20]  A. Hofman,et al.  Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2002, Stroke.

[21]  R. Mayeux,et al.  Metabolic syndrome and dementia risk in a multiethnic elderly cohort , 2007, Journal of the Neurological Sciences.

[22]  S. D. Preston,et al.  Cerebrovascular Disease Is a Major Factor in the Failure of Elimination of Aβ from the Aging Human Brain , 2002 .

[23]  C. Tzourio,et al.  Vascular risk factors and dementia , 2009, Neurology.

[24]  J. Laragh,et al.  The reproducibility of average ambulatory, home, and clinic pressures. , 1988, Hypertension.

[25]  K. Jin,et al.  Microarray analysis of hippocampal gene expression in global cerebral ischemia , 2001, Annals of neurology.

[26]  B. Winblad,et al.  Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. , 2006, Archives of internal medicine.

[27]  J. Schneider,et al.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.

[28]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[29]  H. Chabriat,et al.  Cerebral microhemorrhage. , 2006, Stroke.

[30]  P. Mecocci,et al.  Metabolic Syndrome and Risk of Dementia in Older Adults , 2010, Journal of the American Geriatrics Society.

[31]  P. Scheltens,et al.  Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure , 1998, Neurology.

[32]  A. Hofman,et al.  Cerebral white matter lesions and the risk of dementia. , 2004, Archives of neurology.

[33]  W. Maier,et al.  The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia , 2010, Psychiatry Research: Neuroimaging.

[34]  T. Lumley,et al.  Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. , 2001, Archives of internal medicine.

[35]  Anton P. Porsteinsson,et al.  Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders , 2010, Biological Psychiatry.

[36]  J. Tuomilehto,et al.  Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[37]  A Hofman,et al.  Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.

[38]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[39]  B. Lawlor,et al.  Blood pressure and the risk for dementia—A double edged sword , 2009, Ageing Research Reviews.

[40]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[41]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[42]  O. Hanon,et al.  Vascular risk factors, cognitve decline, and dementia , 2008, Vascular health and risk management.

[43]  T. Nihashi,et al.  Expression and Distribution of Beta Amyloid Precursor Protein and Beta Amyloid Peptide in Reactive Astrocytes After Transient Middle Cerebral Artery Occlusion , 2001, Acta Neurochirurgica.

[44]  Gary A. Ford,et al.  Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure , 2007, Journal of Neurology.

[45]  TilmanWetterling,et al.  Comparison of Different Diagnostic Criteria for Vascular Dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN) , 1996 .

[46]  Matthijs Oudkerk,et al.  Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.

[47]  Gabriel Gold,et al.  Mixed Dementia: Epidemiology, Diagnosis, and Treatment , 2002, Journal of the American Geriatrics Society.

[48]  J. Robins,et al.  A Structural Approach to Selection Bias , 2004, Epidemiology.

[49]  D. Bennett,et al.  Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. , 2001, Archives of neurology.

[50]  S. DeKosky,et al.  Alzheimer disease and mortality: a 15-year epidemiological study. , 2005, Archives of neurology.

[51]  Debra T. Silverman,et al.  Selection of controls in case-control studies. II. Types of controls. , 1992, American journal of epidemiology.

[52]  S. Pappatà,et al.  SPECT imaging of GABAA/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[53]  C. Iadecola,et al.  Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. , 2002, American journal of physiology. Heart and circulatory physiology.

[54]  P. Zandi,et al.  Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study , 2006, Alzheimer disease and associated disorders.

[55]  T G Pickering.  Blood pressure variability and ambulatory monitoring , 1993, Current opinion in nephrology and hypertension.

[56]  Philip Scheltens,et al.  Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study , 2004, Hypertension.

[57]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[58]  B. Winblad,et al.  Decline in Blood Pressure Over Time and Risk of Dementia: A Longitudinal Study From the Kungsholmen Project , 2004, Stroke.

[59]  J. Manfreda,et al.  Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. , 2001, International journal of epidemiology.

[60]  J K McLaughlin,et al.  Selection of controls in case-control studies. I. Principles. , 1992, American journal of epidemiology.

[61]  C B Hall,et al.  Low blood pressure and the risk of dementia in very old individuals , 2003, Neurology.

[62]  A. Hofman,et al.  Measuring Cognitive Function With Age: The Influence of Selection by Health and Survival , 2008, Epidemiology.

[63]  C. Iadecola,et al.  Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[64]  B. Lernfelt,et al.  A population-based study on blood pressure and brain atrophy in 85-year-olds. , 1998, Hypertension.

[65]  W. Markesbery,et al.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆ , 2000, Neurobiology of Aging.

[66]  Carol Brayne,et al.  Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation , 2004, BMC public health.

[67]  N. Fayed,et al.  Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment , 2010, Neurological research.

[68]  D. Le Bihan,et al.  Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. , 2000, Stroke.

[69]  D. Sparks,et al.  Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.

[70]  A. Burns.  Clinical diagnosis of Alzheimer's disease , 1991 .

[71]  Niels D Prins,et al.  Cerebral small-vessel disease and decline in information processing speed, executive function and memory. , 2005, Brain : a journal of neurology.

[72]  T. Manolio,et al.  Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. , 1998, Archives of neurology.

[73]  A. Dyer,et al.  Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. , 2001, Archives of internal medicine.

[74]  M. Stampfer,et al.  Cardiovascular disease and Alzheimer's disease: common links , 2006, Journal of internal medicine.

[75]  H. Chabriat,et al.  Cerebral microhemorrhage. Commentary , 2006 .

[76]  D. Bennett,et al.  LONG-TERM FETAL CELL TRANSPLANT IN HUNTINGTON DISEASE: STAYIN’ ALIVE , 2007, Neurology.

[77]  Zsuzsanna Nagy,et al.  Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease , 1999, The Lancet.

[78]  J. Shi,et al.  Hypoperfusion induces overexpression of β-amyloid precursor protein mRNA in a focal ischemic rodent model , 2000, Brain Research.

[79]  Ihab Hajjar,et al.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.

[80]  H. Chabriat,et al.  Cerebral Atrophy in Cerebrovascular Disorders , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[81]  Arto Mannermaa,et al.  Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.

[82]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[83]  Miguel A Hernán,et al.  Cigarette smoking and dementia: potential selection bias in the elderly. , 2008, Epidemiology.

[84]  J. Robins,et al.  Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.

[85]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[86]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[87]  D. Rosenbaum,et al.  Vascular cognitive impairment: dementia biology and translational animal models. , 2009, Current opinion in investigational drugs.

[88]  H. Hendrie,et al.  Cardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature , 2009, Alzheimer disease and associated disorders.

[89]  [The incidence of dementia among elderly people in Xi' an, China]. , 2005, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[90]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[91]  J. Benito-León,et al.  Risk of incident dementia in drug-untreated arterial hypertension: a population-based study. , 2010, Journal of Alzheimer's disease : JAD.

[92]  K. Anstey,et al.  Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[93]  W. Kukull,et al.  Age‐Varying Association Between Blood Pressure and Risk of Dementia in Those Aged 65 and Older: A Community‐Based Prospective Cohort Study , 2007, Journal of the American Geriatrics Society.

[94]  R. Hébert,et al.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. , 2002, American journal of epidemiology.

[95]  P. Martínez-Martín,et al.  Role of Hypertension in Aggravating Aβ Neuropathology of AD Type and Tau-Mediated Motor Impairment , 2009, Cardiovascular psychiatry and neurology.

[96]  Y. Ihara,et al.  Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. , 1994, The Journal of biological chemistry.

[97]  Chien-Jen Chen,et al.  Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[98]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[99]  P. J. Koudstaal,et al.  Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe , 2005, Neurology.

[100]  L. Berkman,et al.  Cognitive impairment and mortality in the community-dwelling elderly. , 2000, American journal of epidemiology.

[101]  S. D. Preston,et al.  Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease. , 2002, Annals of the New York Academy of Sciences.

[102]  Thomas Lumley,et al.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.

[103]  S. Cole,et al.  Fallibility in estimating direct effects. , 2002, International journal of epidemiology.

[104]  Lawrence J Appel,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.